Combination medicament

Details for Australian Patent Application No. 2003293833 (hide)

Owner Nycomed GmbH

Inventors Weimar, Christian; Dietzel, Klaus; Muller, Helgert; Marx, Degenhard

Agent Griffith Hack

Pub. Number AU-B-2003293833

PCT Number PCT/EP2003/0140

PCT Pub. Number WO2004/052374

Priority 103 06 213.0 13.02.03 DE; 02027797.6 12.12.02 EP

Filing date 11 December 2003

Wipo publication date 30 June 2004

Acceptance publication date 1 October 2009

International Classifications

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

Event Publications

22 April 2004 Complete Application Filed

  Priority application(s): 103 06 213.0 13.02.03 DE; 02027797.6 12.12.02 EP

5 August 2004 Application Open to Public Inspection

  Published as AU-B-2003293833

22 November 2007 Change of Name(s) of Applicant(s), Section 104

  ALTANA Pharma AG The name of the applicant has been changed to Nycomed GmbH 2004

1 October 2009 Application Accepted

  Published as AU-B-2003293833

28 January 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003293834-DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH MUSCARINIC ACETYLCHOLINE RECEPTOR M2 (M2)

2003293832-DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH 5-HYDROXYTRYPTAMINE (SEROTONIN) RECEPTOR 2C (5-HT2C)